Team

Newton Biocapital is managed by life sciences entrepreneur Alain Parthoens. He and his team of experienced industry and venture capital professionals leverage their strategic insights to create value for both patients and investors.

Operational

Alain Parthoens

Alain
Parthoens

ir / Managing Partner / Founder

  • 20 years in the food and biotech industries (Nestle, Monsanto/Searle, PWC)
  • 15 years of venture capital (ING Bank, Vesalius Biocapital)
  • 30 investments in early and neglected late-stage companies, typically as lead investor
  • Director of Ogeda, Promethera Biosciences, Profibrix, Voluntis, NCardia (ex-Pluriomics) and Epics Therapeutics
  • Formerly Chairman of the BVA and member of the Invest Europe VC council
  • Based in Brussels
Els

Els
Hubloux

ir / MBA
Investment Partner

  • 19 years in clinical R&D, financial analysis, and management
  • 14 years in venture capital (KBCPE, Capricorn Venture Partners, QBIC Venture Partners)
  • Over 20 transactions in small biotechs, several IPOs and trade sales
  • Based in Brussels
New Toshiyuki Mori

Toshiyuki Mori

Partner Tokyo Office

  • More than a decade with U.S. National Cancer Institute
  • 9 years in Takeda Pharmaceutical Japan and USA
  • 4 years in healthcare-related fund, responsibility covering fund raising, investments and supports for portfolio companies
  • Certified pharmacist in Japan, PhD of Pharmaceutical Sciences from Hokkaido University
  • Based in Tokyo
Guy Heynen

Guy
Heynen

MD
Senior Clinical &
Regulatory Partner

  • Chief Clinical and Regulatory Officer of Bone Therapeutics (regenerative medicine)
  • Joined Pfizer in 1982; served as Medical Director for Pfizer Switzerland and as International Medical Director up to 2000, and as Regional Medical monitor for Pfizer up to 2014.
  • Independent Director of Ogeda and Pluriomics
Pierre

Pierre
Detrixhe

ir / Master in Management
Investment Partner

  • Background in bio-engineering with previous experience as a scientist in biotech and a technology transfer officer
  • More than 10 years in venture capital (Investsud Group)
  • 10 investments in early stage companies
  • Director at ATB Therapeutics, Bioxodes, Synergia Medical
  • Based in Brussels
Img 4507

Yao Li

BS/MBA

  • 13 years in the financial industry and banking services
  • Various cross-border M&A experiences with deal size over 2 Billion USD
  • Based in Tokyo
Louis

Louis
de Thanhoffer
de Völcsey

Senior Pharma
Biotech Advisor

  • Started his career as a research scientist at the Pasteur Institute and in Pr. Dr. Walter Fiers' Lab of Molecular Biology at the State University of Ghent (Belgium)
  • Joined Janssen Pharmaceutica in 1983 at the request of Dr. Paul Janssen to create the Lab of Molecular Genetics in the Janssen Life Sciences Department
  • In 2000, set up a healthcare/biotech team at Petercam, a Brussels-based stockbrokerage firm (noz Degroof Petercam Bank)
  • From 2008 until 2013, he joined Hunza Ventures, a life sciences private equity fund that belongs to a family office
Danny Gonnissen

Danny
Gonnissen

PhD Appl. Sc. / COO

  • 13 years in industry
  • 8 years of venture capital (Bekaert Venturing, Qbic Fund) with expertise in Direct Investments and Fund Investments
  • Board seats in start-ups & scale-ups
  • Based in Brussels
Dario Padovani

Dario
Padovani

BS CS / EMM
Administration & Finances

  • 20 years in the chemical industry (Monsanto, Searle)
  • 11 years in insurance industry, 8 years in the distribution & logistics industries
  • Based in Brussels
Toko 2 Kopie

Toko Senna

Office Manager

  • Based in Brussels

Independent Board Directors

Ajit

Ajit
Shetty

Chairman
Independent director

  • Formerly CEO, Chairman of Janssen Pharmaceutica
  • Vice President Enterprise Supply Chain for Johnson & Johnson
Dirk

Dirk
Boogmans

Vice-Chairman
Independent director

  • CEO of construction group CFE (1998 - 2001), CEO of GIMV (2001-2008)
  • Board of Director member at BNP Paribas Fortis (Since 2009)
Portrait Ko Sekiguchi 1

Ko Sekiguchi

Indepedent Director

  • Education in Business Management and lecturer at Kenichi Ohmae Graduate School of Business
  • Consultant at Boston Consulting Group, Tokyo office
  • Many years of industry experience at Mitsubishi Corporation, Janssen Pharmaceutical K.K. and Johnson & Johnson Medical K.K.
  • Regional Director DIA (Drug Information Association) Japan
  • Experience as Independent Director (Solasto Corporation, Otsuka Holdings) and Chairman of the Japan-based Executive Committee of the PhRMA
Jean Claude Deschamps

Jean-Claude
Deschamps

Chairman Emeritus

  • Substantial industrial and venture capital experience
  • Instrumental in founding several worldwide recognized projects, including IMEC

Founders

Goro

Goro
Takeda

Alain Parthoens 180627 140520

Alain
Parthoens